BioMedWire Stocks

Could a Medicare Special Needs Plan Be Right for You?

A Special Needs Plan (SNP) customizes medical benefits for individuals who have chronic illnesses, are on Medicaid, or live in specific institutions. SNPs are offered under Medicare Advantage, with figures showing that enrollees under this plan may hit 28% by next year.

What should you know about SNPs?

They cover hospital care (Part A), physician visits and some other charges (Part B) and prescription drugs (Part D).

There are three kinds of SNPs;

  1. Chronic condition SNPs

These plans cover patients with disabling or severe chronic diseases like diabetes, stroke, chronic heart failure, and cancer.

  1. Dual-eligible SNPs

This covers individuals eligible for both Medicaid and Medicare. Individuals who wish to enroll to this particular SNP need to meet their state’s requirements for asset limits and income.

  • Institutional SNPs

This covers individuals who live in a medical institution for at least ninety days. These include nursing homes, inpatient psychiatric facilities, and long-term care facilities.

How do you know if you qualify for an SNP?

Individuals who’d like to enroll to a SNP must meet the aforementioned health requirements or income requirements. This is in addition to qualifying for a Medicare Advantage (MA) plan, which involves enrolling in Original Medicare Parts A and B and living in a service area under the Medicare Advantage plan.

What else should you know?

Once you’ve determined you’re eligible, you can choose a plan. The best time to do this is during Medicare open enrolment, which is open till December 7th. If you’re currently under an MA plan, you can switch your plan during the open enrolment period, which will run from January 1st to March 31st next year.

Individuals who develop qualifying chronic conditions are also eligible to enroll in a chronic condition SNP even when the enrolment period has lapsed. In addition to checking out SNPs available in your area on the Medicare.gov search page, individuals can also:

  • Ensure their medications are covered under the plan they want to enroll in
  • Compare how and if the plan covers your current specialists and physicians
  • Look up how SNP offers special services
  • Review customer feedback and other ratings, with higher star ratings indicating better quality of care and customer service from healthcare providers
  • Research other special benefits that SNPs offer, including home health coverage and dentures
  • Compare how much you’ll pay for prescriptions, doctor’s visits and premiums

Individuals may benefit from using healthcare agents and brokers to compare options and determine which plans they may qualify for. It is also helpful to reach out to MA plan providers like Astiva Health or any other within your area so that you get accurate information about the policy options available to you.

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Microbial Ecosystems Play a Big Role in the Efficacy of Cancer Immunotherapy

Significant strides have been made in leveraging checkpoint inhibitor therapy to combat a number of cancers over the recent…

3 days ago

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands LB 100 Development Through Strategic Academic and Pharma Partnerships

LIXTE recently expanded its ovarian clear cell cancer trial in partnership with MD Anderson and…

3 days ago

California Chooses to Take on Federal Government on Public Health Issues

California, led by Democratic governor Gavin Newsom, has decided to break with the federal positions on public health and…

4 days ago

Earth Science Tech Inc. (ETST) Is Operating a Diversified Portfolio of Businesses in the Pharmaceutical, Healthcare, Telemedicine and Consumer Markets

Earth Science Tech is a holding company that acquires and manages businesses in several markets,…

5 days ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Appoints TMS, Neuroplasticity Researcher Joshua Brown MD, PhD, as Chief Medical Innovation Officer

Prof. Brown is a leading researcher in Transcranial Magnetic Stimulation (“TMS”) and currently serves as…

5 days ago

New Research Challenges Current Thinking on How Brain Cancer Develops

South Korean scientists have published the results of a study that provides vital insights indicating…

6 days ago